Cargando…
The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
BACKGROUND: Postoperative vasoplegia with minimal responsiveness to vasopressors is common after cardiac surgery. Called cardiac vasoplegic syndrome (CVS), it is caused by multiple factors. Treating CVS involves a high dose of fluids and catecholamines, however high doses of catecholamines and fluid...
Autores principales: | Petermichl, Walter, Gruber, Michael, Schoeller, Ina, Allouch, Kwahle, Graf, Bernhard M., Zausig, York A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320154/ https://www.ncbi.nlm.nih.gov/pubmed/34321019 http://dx.doi.org/10.1186/s13019-021-01579-8 |
Ejemplares similares
-
Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018) -
The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017) -
Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017) -
Decatecholaminisation during sepsis
por: Rudiger, Alain, et al.
Publicado: (2016) -
Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)